FDA's TV Review Program Not Commencing

On January 16, 2008, FDA announced that the Direct-to-Consumer (“DTC”) television advertisement user fee program for prescription drugs will not commence because FDA did not receive funding for the program. The user fee program, established by the Food and Drug Administration Amendments Act of 2007 (“FDAAA”), would have allowed companies to pay a user fee to receive an advisory review by FDA of DTC prescription drug television advertisements.


Click the link below to read the full alert.